Zoetis Inc at JPMorgan Healthcare Conference Transcript
Good afternoon, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing Zoetis today. From the company, we have Kristin Peck, the CEO; as well as Wetteny Joseph, who's going to join us for some of the Q&A after the presentation. As a reminder, we've moved away from the formal breakout sessions at the conference this year. So post the presentation, we're going to do some Q&A from the stage.
And with that, I'm going to turn it over to Kristin. Happy New Year, and thanks for joining us.
All right. Well, it is great to be back. Thank you very much, Chris, especially to be back in person and to see so many familiar faces. Before we get into the real front of the day, we got some legal housekeeping. So why don't I kick into that for a second.
As you can probably imagine, we're going to have some forward-looking statements today as well as financials that are non-GAAP. The
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |